Stratipath

Last week, Stratipath CMO Johan Hartman participated in an enlightening seminar at Techarenan during Almedalsveckan in Visby: “AI kan förutse återfall i bröstcancer - Hur påverkar det bröstcancervården?”. Together with partners from the SwAIPP (Swedish AI Precision Pathology) innovation consortium, we discussed the transformative impact of AI solutions in breast cancer diagnostics. Other panelists: Susanne Dieroff Hay, Förbundsordförande, Bröstcancerförbundet Tobias Lundin Gerdås, Ansvarig samhällskontakter, Roche Diagnostics Sweden Moderator: Karin Ekberg, Påverkansansvarig, Bröstcancerförbundet Missed the seminar? Don’t worry! The full talk is now available to stream. Dive into how AI can revolutionize breast cancer care, offering faster, more precise, and cost-effective diagnostics. Watch the video here: https://lnkd.in/dAqnpwch

🏆 Last night, Stratipath was honored with the Dream Award at the Techarenan Challenge in Almedalen. The Dream Award is given to the company that has approached its industry with both heart and mind to bring about revolutionary change. This accolade recognizes those whose business ideas create positive change and contribute to a future to be excited about. We are incredibly grateful and thank the jury for this recognition. #Techarenan #DreamAward #Innovation #Healthcare #AI #PrecisionDiagnostics #Stratipath https://lnkd.in/dqFXs59M

Join us today at 13:00 in Almedalen, Visby! Stratipath's CMO, Johan Hartman, will be part of an engaging panel discussion hosted by Techarenan Focus and SwAIPP (Swedish AI Precision Pathology) titled “AI Can Predict Relapse in Breast Cancer Patients - How Will It Affect Breast Cancer Care?”. The panel will also feature Susanne Dieroff Hay from Bröstcancerförbundet and Tobias Lundin Gerdås from Roche, moderated by Karin Ekberg from Bröstcancerförbundet. Don’t miss this insightful conversation on the future of breast cancer diagnostics and care.

Today at 14.10 (Swedish time) Stratipath CMO Professor Johan Hartman is a panelist at Folkhälsodalen at Almedalen week, Visby. The seminar is titled ”No Precision Medicine without Pathology” and will touch upon AI in diagnostics, digitalization, and new paths for health care. The talk will be in Swedish and is possible to view here >> https://lnkd.in/dEB_Mi4s?

We're excited to announce that Stratipath will be represented at Almedalen Week in Visby, Gotland, by our Chief Medical Officer, Professor Johan Hartman, and Customer Service Specialist, Emelie Karlsson. For more information or to connect with us, please reach out! The Almedalen program (from a Stratipath view): Stratipath is a proud finalist in the Techarenan Start-up Challenge. We'll present our closed pitch and be part of the exhibition at the Techarenan area in Almedalen. Stay tuned for the winner announcement on Thursday. On Wednesday, June 26th, Johan Hartman will be a panelist in the seminar “Ingen precisionsmedicin utan patologi” (No precision medicine without Pathology) at Folkhälsodalen, arranged by Karolinska Institutet and the Swedish Association of Pathology, along with AstraZeneca and Eli Lilly and Company.  The esteemed panelists include: Anna Bodén, Chief Physician in Pathology at Linköping University Hospital and Digital Project Manager for DigiPat, Marie-Louise Hänel Sandström (M), General Practitioner and Member of the Education Committee and Social Committee, as well as Vice Chair of RIFO, Simon Ekman, Professor and Chief Physician in Oncology at Karolinska Institute and Karolinska University Hospital, Susanne Dieroff Hay , Chair of the Bröstcancerförbundet The seminar will be moderated by Göran Hägglund from the Reform Society and will be live-streamed here >> https://lnkd.in/dt3n8yyx Additionally, on Thursday at 13:00, SwAIPP (Swedish AI Precision Pathology, in which Stratipath is a partner) is hosting a seminar titled "AI can predict relapse in breast cancer - How may that affect breast cancer care?" Panelists include Johan Hartman, Susanne Dieroff Hay from Bröstcancerförbundet, and Tobias Lundin Gerdås, Policy & Governmental Affairs Partner at Roche Diagnostics Sweden. The seminar will be moderated by Karin Ekberg from Bröstcancerförbundet. Looking forward to engaging with the community and advancing the conversation on precision diagnostics!

Last week was filled with awards, conferences, and exciting meetings. This week, we are delighted to share an interview with Stratipath co-founder Professor Johan Hartman, where he discusses the future of precision diagnostics in Medtech Magazine. (The article in Swedish). "Stratipath Breast is the first solution of its kind in the world that can provide prognostic information, predicting outcomes for breast cancer patients. Previous technologies were based on gene expression, but few patients had access to those analysis methods. With AI, you can achieve much greater accessibility and faster results." / Johan Hartman, MedTech magazine

If you're planning to attend ESMO Breast, we are excited to announce that Stratipath will be represented by our dedicated team including CEO Fredrik Wetterhall, CMO Johan Hartman, and Customer Service Specialist Emelie Karlsson. We invite you to learn more about Stratipath Breast, our innovative AI-based risk profiling solution for breast cancer. Please feel free to reach out for a meeting or a casual chat to discuss how we can support your work with cutting-edge diagnostic tools. Looking forward to connecting with you at the event! https://lnkd.in/dgyBz9py

This Wednesday through Friday, visit Stratipath at the Spring Meeting of the Swedish Association for Pathology in Kalmar. As proud sponsors, we are excited to connect with you at booth 13. Don't miss the chance to meet our COO, Annica Jämtén Ericsson, and our Medical Manager and Pathologist, Stephanie Robertson. Stop by to discover how Stratipath is pioneering the future of pathology with AI-driven diagnostics.

Join us this Wednesday morning at 9:30 AM at Vitalis for a captivating presentation by Stratipath's Co-founder, Professor Johan Hartman. He'll be discussing "AI-Based Cancer Diagnostics for Cost-Effective Precision Medicine."

Super proud! 🍾Stratipath is the winner of the Health Tech Award 2024 at Vitalis! Jury motivation: For delivering an innovation that provides equal access to advanced clinical evaluations, this year’s winner introduces AI-based precision diagnostics to enhance cancer treatment decisions and patient outcomes. This innovation not only offers measurable benefits on a large scale, it also makes infection point technology globally accessible at low cost. The benefit is here and now, far beyond potential. The HealthTech Award 2024, sponsored by Vitalis, GREAT and Sahlgrenska Science Park, proudly recognizes and congratulates Stratipath!